|
시장보고서
상품코드
2058579
체외진단용 의약품(IVD) 품질관리 시장 : 제품 및 서비스별, 용도별, 제조업체 유형별, 최종사용자별, 국가별, 지역별 - 세계 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)In Vitro Diagnostics (IVD) Quality Control Market, By Product and Service, By Application, By Manufacturer Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
체외진단용 의료기기(IVD) 품질관리 시장 규모는 2025년에 16억 6,050만 달러로 평가되며, 2026-2033년에 CAGR 6.1%로 확대할 것으로 전망되고 있습니다.
체외진단(IVD) 품질관리란, 검사실에서 수행되는 진단 검사가 정확하고 일관되며 신뢰할 수 있는 결과를 도출하도록 보장하기 위해 사용되는 일련의 자재, 공정 및 절차를 의미합니다. 여기에는 장비, 시약 및 검사 방법이 올바르게 작동하는지 확인하기 위해 환자 검체와 함께 검사되는 관리 검체의 사용이 포함됩니다. 이를 통해 검사실은 오류를 조기에 발견하고, 검사 기준을 유지하며, 정확한 임상 판단을 지원할 수 있습니다. 이는 특히 병원, 검사 기관 및 조사 현장에서 결과의 정확성과 재현성이 환자 치료에 있으며, 매우 중요하므로 진단 워크플로의 필수적인 부분입니다.
중국의 국가약품감독관리국(NMPA), 인도의 중앙의약품표준관리기구(CDSCO), 일본의 후생노동성(MHLW) 등 정부 기관들은 진단 검사 및 검사실 품질 보증에 관한 지침을 강화하기 위해 적극적으로 노력하고 있습니다. 이러한 규제 조치에 따라 의료 제공자들은 신뢰할 수 있는 검사 성능을 확보하기 위해 체계적인 품질관리 체계를 도입하도록 권장받고 있습니다. 세계보건기구(WHO) 등 국제기구들도 질병 탐지 및 공중보건 감시를 위한 표준화된 실험실 운영을 추진하고 있습니다. 이러한 노력들이 결합되어 검사실내 환경을 더욱 균일하게 만들고, 검사 결과의 신뢰성을 높이는 데 기여하고 있습니다.
체외진단용 의약품(IVD) 품질관리 시장 - 시장 역학
진단 정확도와 환자 안전에 대한 관심 증가
진단 정확도와 환자 안전에 대한 관심이 높아짐에 따라 검사실이 검사 오류를 최소화하고 신뢰할 수 있는 임상 판단을 확보하고자 노력하는 가운데, 체외진단용 의료기기(IVD) 품질관리 솔루션에 대한 수요가 꾸준히 증가하고 있습니다. 미국과 유럽 이외의 각국 정부도 체계적인 검사실 기준을 통해 이러한 방향을 강화하고 있습니다. 예를 들어 중국 국가약품감독관리국(NMPA)은 진단용 시약의 승인 및 시판 후 감시 요건을 강화하여, 보다 엄격한 품질 검증 관행을 장려하고 있습니다.
인도에서는 중앙의약품표준관리기구(CDSCO)로 알려진 규제 당국이 검사 프로토콜에 관한 지침을 제공함으로써 체외진단용 의약품에 대한 규제를 강화하고 있습니다. 업계에서는 로슈 다이아그노스틱스와 바이오래드 래버러토리즈가 검사실이 일관된 교정과 신뢰할 수 있는 결과를 유지할 수 있도록 지원하는 통합 품질관리 시스템을 제공하고 있으며, 이를 통해 모든 임상 환경에서 환자의 안전과 진단 보고서의 신뢰성이 강화되고 있습니다.
체외진단(IVD) 품질관리 시장 ? 시장 세분화 분석:
전 세계 체외진단(IVD) 품질관리 시장은 제품·서비스, 용도, 제조업체 유형, 최종사용자 및 지역별로 세분화되어 있습니다.
제조 유형의 경우, 자동 분석 장치 시스템 및 검사실 워크플로우의 정확도 요건과 밀접하게 연계되어 있으므로, 장비 전용 제어 시스템이 주요 부문이 될 것으로 전망됩니다. 이러한 제어 장치는 특정 진단 장비와 직접 연동되도록 설계되어, 검사실이 일관된 교정을 유지하고 분석의 편차를 줄이며 신뢰할 수 있는 검사 결과를 확보하는 데 도움이 됩니다. 검사실이 시스템 간 호환성이 필수적인 고처리량 및 자동화된 검사 환경으로 전환됨에 따라 그 중요성은 더욱 커지고 있습니다. 또한 Bio-Rad Laboratories사는 임상화학 및 면역분석 검사 시스템에서 일반적으로 사용되는 기기에 맞춰 맞춤 제작된 대조 재료를 제공하고 있습니다. 이에 더해, Thermo Fisher Scientific사가 주도하는 검사실 자동화의 발전으로 인해 장비의 표준화가 진행되어, 워크플로우 개선과 결과의 신뢰성 향상으로 이어지고 있습니다.
체외진단(IVD) 품질관리 시장 - 지역별 분석
체외진단(IVD) 품질관리 시장의 지역별 성장은 엄격한 실험실 규제, 진단 검사 건수의 증가, 그리고 의료 네트워크 전반에 걸친 자동화 품질 보증 시스템의 도입 확대에 의해 주도되고 있습니다. 세계 각 지역 중에서 북미 및 아시아태평양은 견고한 규제 체계, 확대되는 임상 검사실 인프라, 그리고 진단 정확도 시스템에 대한 지속적인 투자 덕분에 앞으로도 가장 영향력 있는 지역으로 남을 것으로 예상됩니다. 북미는 미국 식품의약국(FDA), 메디케어·메디케이드 서비스 센터(CMS) 산하의 임상검사개선법(CLIA), 그리고 캐나다 보건부 등의 기관에 의한 규제 감독을 바탕으로 확고한 입지를 유지하고 있습니다. 이 기관들은 공동으로 임상 검사실에서의 엄격한 품질관리 준수를 철저히 이동하고 있습니다. 또한 미국 질병통제예방센터(CDC)는 검사실의 품질 기준 및 질병 감시 프로그램을 지원하고 있습니다. 기업 측면에서는 로슈 다이아그노스틱스(Roche Diagnostics)나 서모피셔 사이언티픽(Thermo Fisher Scientific)과 같은 기업이 규제 요건에 부합하는 검사실 도입 동향을 반영하여, 자동화된 진단 시스템과 데이터 관리 통합 기능을 통해 검사실의 품질관리(QC) 생태계를 강화하고 있습니다. 이 지역은 고도로 체계화된 진단 환경과 광범위한 인증 제도의 혜택을 지속적으로 누리고 있으며, 이러한 요인들이 품질관리 제품에 대한 꾸준한 수요를 지원하고 있습니다.
또한 아시아태평양은 중국, 인도, 일본 등 국가들의 병원 네트워크가 급속히 확대되고, 진단에 대한 인식이 높아지며, 정부 주도의 의료 현대화 프로그램이 추진됨에 따라 계속해서 강력한 영향력을 유지할 것으로 예상됩니다. 중국의 국가약품감독관리국(NMPA), 인도의 중앙의약품표준관리기구(CDSCO), 일본의 후생노동성(MHLW) 등 규제 당국은 진단의 신뢰성을 높이기 위해 검사 기준 및 외부 품질 평가 시스템 강화에 적극적으로 나서고 있습니다. 정부 주도의 선별 검사 프로그램 및 검사 인프라에 대한 투자 확대는 해당 지역 전체의 품질관리 솔루션에 대한 수요를 지속적으로 지원하고 있습니다. 업계에서는 시스멕스 주식회사와 애보트 래버러토리스 등의 기업이 대량 검사 환경에 최적화된 자동 분석 장비와 표준화된 QC 재료를 활용하여 진단 포트폴리오를 확대하고 있습니다. 이러한 요인들이 복합적으로 작용하고, 공중보건 구상과 민간 부문의 혁신이 모두 지원되면서, 아시아태평양은 진단 품질 보증 시스템의 급속히 확장되는 거점으로서의 입지를 확고히 하고 있습니다.
인도 체외진단용 의약품(IVD) 품질관리 시장 - 국가별 분석
인도는 진단에 대한 의식의 향상, 환자 선별 검사 활동의 증가, 그리고 검사실 기반 의료 서비스에 대한 의존도 상승에 힘입어 체외진단(IVD) 품질관리 시장에서의 입지를 점차 공고히 하고 있습니다. 이 국가의 의료 시스템에서는 진단 인프라가 꾸준히 개선되고 있으며, 도시 지역의 병원과 신생 진단 체인 모두 검사 결과의 정확성, 추적 가능성 및 표준화에 주력하고 있습니다. 이러한 변화에 따라 검사 오류를 줄이고 결과의 신뢰성을 높이기 위해, 임상검사실에서의 품질관리 재료 및 자동 검증 시스템의 활용이 확대되고 있습니다.
이러한 성장 환경에는 병리학 및 분자 진단 분야의 첨단 검사 기법 보급뿐만 아니라, 소규모 의료 시설에서 대규모 참조 실험실로 검사 업무를 아웃소싱하는 사례가 증가한 점도 영향을 미치고 있습니다. 예방 의료 및 질환의 조기 발견에 대한 관심이 높아짐에 따라 진단 워크플로우 전반에 걸친 일관된 품질 보증의 실천 필요성이 더욱 강조되고 있습니다. 또한 검사실에서의 디지털 통합 발전은 데이터 관리 및 결과 검증 프로세스의 개선에 기여하고 있습니다. 이러한 추세가 맞물리면서, 인도에서는 보다 체계적이고 품질을 중시하는 진단 생태계가 구축되고 있습니다.
목차
제1장 체외진단용 의약품(IVD) 품질관리 시장 개요
제2장 개요
제3장 체외진단용 의약품(IVD) 품질관리 주요 시장 동향
제4장 체외진단용 의약품(IVD) 품질관리 산업 분석
제5장 체외진단용 의약품(IVD) 품질관리 시장 : 높아지는 지정학적 긴장의 영향
제6장 체외진단용 의약품(IVD) 품질관리 시장 구도
제7장 체외진단용 의약품(IVD) 품질관리 시장 : 제품·서비스별
제8장 체외진단용 의약품(IVD) 품질관리 시장 : 용도별
제9장 체외진단용 의약품(IVD) 품질관리 시장 : 제조업체 유형별
제10장 체외진단용 의약품(IVD) 품질관리 시장 : 최종사용자별
제11장 체외진단용 의약품(IVD) 품질관리 시장 : 지역별
제12장 주요 벤더 분석 : 체외진단용 의약품(IVD) 품질관리 산업
제13장 AnalystView의 전방위 전망
KSAIn Vitro Diagnostics (IVD) Quality Control Market size was valued at US$ 1,660.5 Million in 2025, expanding at a CAGR of 6.1% from 2026 to 2033.
In Vitro Diagnostics (IVD) Quality Control refers to the set of materials, processes, and procedures used to ensure that diagnostic tests performed in laboratories produce accurate, consistent, and reliable results. It involves the use of control samples that are tested alongside patient specimens to verify that instruments, reagents, and testing methods are functioning correctly. This helps laboratories detect errors early, maintain testing standards, and support correct clinical decision-making. It is an essential part of diagnostic workflows, especially in hospitals, reference laboratories, and research settings where precision and repeatability of results are critical for patient care.
Government bodies such as China's National Medical Products Administration (NMPA), India's Central Drugs Standard Control Organization (CDSCO), and Japan's Ministry of Health, Labour and Welfare (MHLW) are actively strengthening guidelines for diagnostic testing and laboratory quality assurance. These regulatory efforts are encouraging healthcare providers to adopt structured quality control practices to ensure reliable test performance. International organizations such as the World Health Organization (WHO) also promote standardized laboratory practices for disease detection and public health surveillance. Collectively, these structures have helped foster more uniform conditions within laboratories and increased confidence in laboratory findings.
In Vitro Diagnostics (IVD) Quality Control Market- Market Dynamics
Rising focus on diagnostic accuracy and patient safety
The rising focus on diagnostic accuracy and patient safety is steadily strengthening demand for In Vitro Diagnostics (IVD) Quality Control solutions, as laboratories aim to minimize testing errors and ensure dependable clinical decisions. Governments outside the U.S. and Europe are reinforcing this direction through structured laboratory standards. For example, China's National Medical Products Administration (NMPA) has tightened approval and post-market surveillance requirements for diagnostic reagents, encouraging stronger quality verification practices.
In India, the regulatory body known as the Central Drugs Standard Control Organization (CDSCO) has been making efforts to tighten up regulation of in-vitro diagnostics by providing guidelines for testing protocols. On the industry side, Roche Diagnostics and Bio-Rad Laboratories provide integrated quality control systems that help laboratories maintain consistent calibration and reliable results, reinforcing patient safety and confidence in diagnostic reporting across clinical environments.
In Vitro Diagnostics (IVD) Quality Control Market- Segmentation Analysis:
The Global In Vitro Diagnostics (IVD) Quality Control Market is segmented on the basis of Product and Service, Application, Manufacturer Type, End User, and Region.
In terms of manufacturing type, instrument-specific controls are likely to be a key segment due to their close alignment with automated analyzer systems and laboratory workflow precision requirements. These controls are designed to work directly with specific diagnostic instruments, helping laboratories maintain consistent calibration, reduce analytical variation, and ensure reliable test outputs. Their importance is increasing as laboratories shift toward high-throughput and automated testing environments where system compatibility becomes essential Moreover, Bio-Rad Laboratories offers control materials customized to the instruments that are commonly used in clinical chemistry and immunoassay test systems. This is additionally complemented by advances in laboratory automation championed by Thermo Fisher Scientific, whereby instrument standardization leads to improved workflow and accountability of results.
In Vitro Diagnostics (IVD) Quality Control Market- Geographical Insights
The geographical development of the In Vitro Diagnostics (IVD) Quality Control market is shaped by strict laboratory regulations, rising diagnostic test volumes, and increasing adoption of automated quality assurance systems across healthcare networks. Across global regions, North America and Asia-Pacific are expected to remain the most influential areas due to their strong regulatory frameworks, expanding clinical laboratory infrastructure, and continuous investments in diagnostic accuracy systems. North America maintains a strong position supported by regulatory oversight from agencies such as the U.S. Food and Drug Administration (FDA), Clinical Laboratory Improvement Amendments (CLIA) under the Centers for Medicare & Medicaid Services (CMS), and Health Canada, which collectively enforce strict quality control compliance in clinical laboratories. In addition, the U.S. Centers for Disease Control and Prevention (CDC) support laboratory quality standards and disease surveillance programs. In terms of companies, organizations like Roche Diagnostics and Thermo Fisher Scientific have enhanced laboratory QC ecosystems via automated diagnostic systems and data management integration capabilities, in light of laboratory adoption trends in line with regulatory requirements. The region continues to benefit from a highly structured diagnostic environment and widespread accreditation systems that sustain consistent demand for quality control products.
Asia-Pacific is also expected to maintain a strong influence due to the rapid expansion of hospital networks, increasing diagnostic awareness, and government-led healthcare modernization programs across countries such as China, India, and Japan. Regulatory bodies, including China's National Medical Products Administration (NMPA), India's Central Drugs Standard Control Organization (CDSCO), and Japan's Ministry of Health, Labour and Welfare (MHLW) are actively strengthening laboratory testing standards and external quality assessment systems to improve diagnostic reliability. Government-backed screening programs and rising investment in laboratory infrastructure continue to support demand for quality control solutions across the region. On the industry side, companies such as Sysmex Corporation and Abbott Laboratories are expanding their diagnostic portfolios with automated analyzers and standardized QC materials tailored for high-volume testing environments. Together, these factors position Asia-Pacific as a rapidly expanding hub for diagnostic quality assurance systems, supported by both public health initiatives and private sector innovation.
India In Vitro Diagnostics (IVD) Quality Control Market- Country Insights
India is gradually strengthening its position in the In Vitro Diagnostics (IVD) Quality Control market, supported by expanding diagnostic awareness, rising patient screening activities, and increasing reliance on laboratory-based healthcare services. The country's healthcare system is witnessing steady improvement in diagnostic infrastructure, where both urban hospitals and emerging diagnostic chains are focusing on accuracy, traceability, and standardization of test results. This shift is encouraging greater use of quality control materials and automated verification systems in clinical laboratories to reduce testing errors and improve reliability of outcomes.
The growth environment is also influenced by the wider adoption of advanced testing methods in pathology and molecular diagnostics, along with increasing outsourcing of laboratory services by smaller healthcare centers to larger reference labs. Rising focus on preventive healthcare and early disease detection is further supporting the need for consistent quality assurance practices in diagnostic workflows. In addition, growing digital integration in laboratories is helping improve data management and result validation processes. Collectively, these developments are creating a more structured and quality-focused diagnostic ecosystem in India.
In Vitro Diagnostics (IVD) Quality Control Market- Competitive Landscape:
The In Vitro Diagnostics (IVD) Quality Control market is shaped by the presence of multinational healthcare End User providers and specialized laboratory solution developers focusing on consistent testing accuracy and regulatory alignment. Companies including Bio-Rad Laboratories, Thermo Fisher Scientific, Randox Laboratories, and Roche Diagnostics strengthen their position through automated quality control products, digital laboratory connectivity, and broader assay portfolios. Products are supplied through hospital procurement channels, diagnostic laboratories, regional distributors, and direct service agreements. Manufacturers also focus on laboratory workflow efficiency, reagent stability, and compliance support to strengthen long-term customer relationships across clinical testing environments.
Industry participants continue expanding their presence through collaborations, acquisitions, and advanced diagnostic quality solutions. In March 2026, Abbott Laboratories completed the acquisition of Exact Sciences to strengthen its molecular diagnostics and cancer testing capabilities, supporting wider access to precision diagnostic solutions. In April 2026, QuidelOrtho finalized the acquisition of LEX Diagnostics, adding rapid PCR testing technologies to its diagnostic operations for faster laboratory-quality results. Such developments reflect how organizations are focusing on automation, rapid disease detection, and dependable testing standards to support healthcare providers and diagnostic laboratories in routine clinical decision-making
Recent Developments:
In March 2026, Integrated DNA Technologies introduced its first in vitro diagnostic next-generation sequencing assays under the Archer platform. The launch was designed to improve standardized oncology testing workflows while supporting laboratories with quality-focused and regulatory-aligned molecular diagnostic solutions.
In January 2026, Gentian Diagnostics entered an exclusive collaboration with a global diagnostics manufacturer to develop a novel diagnostic assay for integration into widely used clinical chemistry analyzer systems. The initiative is focused on strengthening automated assay performance, validation processes, and scalable in vitro diagnostic quality solutions for laboratory applications
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Abbott Laboratories
- F. Hoffmann-La Roche
- Siemens Healthineers
- Randox Laboratories
- QuidelOrtho
- Sysmex Corporation
- Danaher Corporation
- Becton Dickinson
- bioMerieux
- QIAGEN
- Agilent Technologies
- Hologic
- Merck KGaA
- Helena Laboratories
- Technopath Clinical Diagnostics
- Streck
- ZeptoMetrix
- Microbiologics
- LGC Group
- SeraCare Life Sciences
- Sun Diagnostics
- Others
GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT AND SERVICE- MARKET ANALYSIS, 2020 - 2033
- Quality Control Products
- Whole Blood-Based Controls
- Serum/Plasma-Based Controls
- Urine-Based Controls
- Multi-Analyte Controls
- Others
- Data Management Solutions
- Quality Assurance Services
GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular Diagnostics
- Microbiology
- Coagulation & Hemostasis
- Others
GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY MANUFACTURER TYPE- MARKET ANALYSIS, 2020 - 2033
- Third-Party Quality Controls
- Instrument-Specific Quality Controls
GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Clinical Laboratories
- Academic & Research Institutes
- Others
GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. In Vitro Diagnostics (IVD) Quality Control Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. In Vitro Diagnostics (IVD) Quality Control Market Snippet by Product and Service
- 2.1.2. In Vitro Diagnostics (IVD) Quality Control Market Snippet by Application
- 2.1.3. In Vitro Diagnostics (IVD) Quality Control Market Snippet by Manufacturer Type
- 2.1.4. In Vitro Diagnostics (IVD) Quality Control Market Snippet by End User
- 2.1.5. In Vitro Diagnostics (IVD) Quality Control Market Snippet by Country
- 2.1.6. In Vitro Diagnostics (IVD) Quality Control Market Snippet by Region
- 2.2. Competitive Insights
3. In Vitro Diagnostics (IVD) Quality Control Key Market Trends
- 3.1. In Vitro Diagnostics (IVD) Quality Control Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. In Vitro Diagnostics (IVD) Quality Control Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. In Vitro Diagnostics (IVD) Quality Control Market Opportunities
- 3.4. In Vitro Diagnostics (IVD) Quality Control Market Future Trends
4. In Vitro Diagnostics (IVD) Quality Control Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. In Vitro Diagnostics (IVD) Quality Control Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. In Vitro Diagnostics (IVD) Quality Control Market Landscape
- 6.1. In Vitro Diagnostics (IVD) Quality Control Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. In Vitro Diagnostics (IVD) Quality Control Market - By Product and Service
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product and Service, 2025 & 2033 (%)
- 7.1.2. Quality Control Products
- 7.1.2.1. Whole Blood-Based Controls
- 7.1.2.2. Serum/Plasma-Based Controls
- 7.1.2.3. Urine-Based Controls
- 7.1.2.4. Multi-Analyte Controls
- 7.1.2.5. Others
- 7.1.3. Data Management Solutions
- 7.1.4. Quality Assurance Services
8. In Vitro Diagnostics (IVD) Quality Control Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Clinical Chemistry
- 8.1.3. Immunochemistry
- 8.1.4. Hematology
- 8.1.5. Molecular Diagnostics
- 8.1.6. Microbiology
- 8.1.7. Coagulation & Hemostasis
- 8.1.8. Others
9. In Vitro Diagnostics (IVD) Quality Control Market - By Manufacturer Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Manufacturer Type, 2025 & 2033 (%)
- 9.1.2. Third-Party Controls
- 9.1.3. Instrument-Specific Controls
10. In Vitro Diagnostics (IVD) Quality Control Market - By End User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinical Laboratories
- 10.1.4. Academic & Research Institutes
- 10.1.5. Others
11. In Vitro Diagnostics (IVD) Quality Control Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. In Vitro Diagnostics (IVD) Quality Control Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. In Vitro Diagnostics (IVD) Quality Control Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.17.3. Poland Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.17.5. Denmark Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
- 11.3.18.1. Overview
- 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.18.5. Rest of the Europe Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. In Vitro Diagnostics (IVD) Quality Control Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.16.3. Taiwan Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.16.5. Taiwan Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
- 11.4.17.1. Overview
- 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.17.3. Vietnam Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.17.5. Vietnam Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
- 11.4.18.1. Overview
- 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.18.3. Rest of APAC Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.18.5. Rest of APAC Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. In Vitro Diagnostics (IVD) Quality Control Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. In Vitro Diagnostics (IVD) Quality Control Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.14.3. Iran Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.14.5. Iran Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
- 11.6.15.1. Overview
- 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.15.3. Qatar Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.15.5. Qatar Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
- 11.6.16.1. Overview
- 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.16.3. Rest of MEA Market Size and Forecast, By Product and Service, 2020 - 2033 (US$ Million)
- 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.16.5. Rest of MEA Market Size and Forecast, By Manufacturer Type, 2020 - 2033 (US$ Million)
- 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- In Vitro Diagnostics (IVD) Quality Control Industry
- 12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Bio-Rad Laboratories
- 12.2.2. Thermo Fisher Scientific
- 12.2.3. Abbott Laboratories
- 12.2.4. F. Hoffmann-La Roche
- 12.2.5. Siemens Healthineers
- 12.2.6. Randox Laboratories
- 12.2.7. QuidelOrtho
- 12.2.8. Sysmex Corporation
- 12.2.9. Danaher Corporation
- 12.2.10. Becton Dickinson
- 12.2.11. bioMerieux
- 12.2.12. QIAGEN
- 12.2.13. Agilent Technologies
- 12.2.14. Hologic
- 12.2.15. Merck KGaA
- 12.2.16. Helena Laboratories
- 12.2.17. Technopath Clinical Diagnostics
- 12.2.18. Streck
- 12.2.19. ZeptoMetrix
- 12.2.20. Microbiologics
- 12.2.21. LGC Group
- 12.2.22. SeraCare Life Sciences
- 12.2.23. Sun Diagnostics
- 12.2.24. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
